ReviewClinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery2026
Comparing Quality of Life in Smell and Taste Disorders With Other Chronic Conditions-A Narrative Review.
Review in Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The APOLLO trial: a proof-of-concept study for vitamin A nasal drops in COVID-19-related postinfectious olfactory dysfunction.Chemical senses · 2026Trial
- The Need to Promote Olfactory Health in Public Health Agendas Across the Globe.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesSmell and taste disorders (SATDs) are increasingly prevalent but remain underrecognised, significantly affecting patients' physical, social and psychological well-being. We recently published a large cohort study reporting Olfactory Disorder Questionnaire (ODQ), EQ-5D-5L (EuroQol Five-Dimension Five-Level) and EQ-5D-5L Visual Analogue Scale (VAS) scores for patients with SATDs. These results highlight the considerable impact of SATDs on quality of life and mental health. This review seeks to evaluate the disease burden of SATDs by comparing their impact on quality of life and mental health with other chronic conditions, using established metrics such as EQ-5D-5L and BDI from the existing literature.
methodsA literature review was conducted from 1 January 2010 to 10 August 2024, to identify systematic reviews reporting EQ-5D-5L or BDI values in chronic conditions.
resultsOur findings show that EQ-5D-5L and BDI scores for patients with SATDs are comparable to those reported for other chronic conditions, including diabetes, stroke, cardiovascular, respiratory and ENT disorders.
conclusionThese results highlight the significant burden olfactory dysfunction imposes on individuals. However, unlike other chronic conditions with established treatment protocols, effective therapies for SATDs remain limited, emphasising a critical gap in both research and care. Increased awareness and further research are essential to develop effective treatments and improve outcomes for this often-overlooked population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.